Dr. Adwan is the Co-Founder and Chief Scientific Officer of TaliaGen, where he leads innovation in precision medicine and personalized wellness. His mission is simple: use cutting-edge genetic science to help people make smarter, more personalized decisions about their health.

His work focuses on turning complex molecular research into practical tools that improve prevention, diagnosis, and treatment. By integrating pharmacogenomics and nutrigenomics into real-world healthcare, Dr. Adwan helps clinicians and patients better understand how genetics influence medication response, nutrient needs, and overall health outcomes.

At TaliaGen, he leads the development of advanced genomic and multi-omic testing designed to optimize therapeutic choices, enhance performance, and support proactive, data-driven wellness strategies. His approach bridges science and application—ensuring that innovation doesn’t stay in the lab, but translates into meaningful improvements in everyday health.

Dr. Adwan earned his degree in Biology and Chemistry with honors from Misericordia University and completed his Ph.D. in Cell, Stem Cell, and Developmental Biology at the University of Colorado, where he also conducted postdoctoral research. He is a recipient of the National Research Service Award from the National Institutes of Health and serves as a certified high-complexity laboratory director in molecular diagnostics.

An active contributor to national genomic medicine initiatives, including participation in the Clinical Pharmacogenetics Implementation Consortium, Dr. Adwan regularly presents on personalized medicine, genetic testing, and the future of preventive healthcare.